MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2017 International Congress

    Perceptual and acoustical analysis of speech in multiple system atrophy and progressive supranuclear palsy.

    S. Contardi, A. Gessani, F. Cavallieri, C. Budriesi, A. Bernardi, M. Tondelli, E. Menozzi, A. Chiari, P. Nichelli, F. Valzania (Modena, Italy)

    Objective: The aim of this study was to characterize speech impairment in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) with a standardized approach,…
  • 2017 International Congress

    Diffusion-Weighted MRI discriminates Parkinson´s Disease from the Parkinsonian Variant of Multiple System Atrophy: a Meta-analysis

    S. Bajaj, F. Krismer, G. Wenning, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: A systematic review and meta-analysis was performed to evaluate the diagnostic accuracy of DWI in the differential diagnosis of the parkinsonian variant of multiple…
  • 2017 International Congress

    Non-motor symptoms and gender differences in multiple system atrophy

    S. Eschlboeck, T. Benke, S. Bösch, M. Delazer, A. Djamshidian-Tehrani, A. Fanciulli, R. Granata, B. Högl, C. Kaindlstorfer, G. Kiss, F. Krismer, K. Mair, M. Nocker, C. Raccagni, C. Scherfler, K. Seppi, A. Stefani, W. Poewe, G. Wenning (Innsbruck, Austria)

    Objective: Objective: To determine the frequency and gender differences of non-motor symptoms (NMS) in patients with multiple system atrophy (MSA).  Background: Background: NMS are a…
  • 2017 International Congress

    The environmental and genetic risk factors in multiple system atrophy in a Taiwanese population

    M.-C. Kuo, Y.-C. Lu, M.-L. Chen, C.-H. Tai, C.-H. Lin, R.-M. Wu (Taipei, Taiwan)

    Objective: The etiology of MSA remains uncertain. Cholesterol and its metabolism derangements, α-Synuclein and CoQ2 genetic polymorphism have been disclosed to be associated with the…
  • 2017 International Congress

    Differentiating Parkinsonism with Spatio-temporal dynamics (real-time MRI) and Acoustics of Speech (spectrogram)

    S. GUDWANI, S.S. Kumaran, M. Behari (New Delhi, India)

    Objective: Differentially diagnosing subgroups in Parkinsonism for optimal rehabilitation thus designed study with real-time dynamic magnetic resonance imaging (MRI) and automated acoustic analysis Background: In Parkinsonism with…
  • 2017 International Congress

    Semiquantitative analyses of DAT-SPECT imaging with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism

    N. Morimoto, M. Takamiya, M. Morimoto (Takamatsu, Japan)

    Objective: We investigate the usefulness Dopamine transporter (DAT)-SPECT with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism. Background: DAT-SPECT imaging is sensitive…
  • 2017 International Congress

    Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study

    E. Fiorenzato, L. Weis, A. Antonini, R. Biundo (Venice-Lido, Italy)

    Objective: To characterize the progression of cognitive decline and compare the neuropsychological 15-month profile across PSP, MSA and PD. Background: Cognitive impairments are frequently reported in…
  • 2017 International Congress

    Predictors of cognitive impairment in multiple system atrophy

    M. Hatakeyama, T. Sato, T. Takahashi, M. Kanazawa, O. Onodera, M. Nishizawa (Niigata, Japan)

    Objective: To determine predictors of cognitive impairment in patients with multiple system atrophy (MSA). Background: Although dementia is not a diagnostic criteria for MSA, an…
  • 2017 International Congress

    Clinical Phenotype in Patients with Multiple System Atrophy in the Mexican Population

    S. Isais-Millán, C. Perez-Lohman, K. Salinas Barboza, A. Cervantes Arriaga, M. Rodriguez Violante, L. Mendoza Vega, N. Davila Avila, A. DelaCruz Landero (Mexico City, Mexico)

    Objective: To describe the clinical phenotype of patients with MSA in a center in Mexico City Background: Multiple System Atrophy (MSA) is an adult-onset;progressive,neurodegenerative disease…
  • 2016 International Congress

    The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

    M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

    Objective: To examine the extent of disease progression for multiple system atrophy (MSA) during relatively long duration. Background: The knowledge of MSA natural history is…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley